Recent Courses

EHA 2016: New Therapeutic Strategies for the Management of Patients with...
  • 1.00 AMA PRA Category 1 Credit(s)™ credit
  • 1.00 Non-physician credit
This CME program will cover data on new therapeutic strategies for the management of patients with relapsed-refractory multiple myeloma that were presented at the European Hematology Association 2016 Annual Congress in Copenhagen, Denmark on June 9 - 12, 2016. The expert faculty of this program will discuss tumor science, including relapsed,...
Current Strategies for the Long-term Assessment, Monitoring, and Management of...
  • 1.50 AMA PRA Category 1 Credit(s)™ credits
  • 1.50 Non-physician credits
  • 1.50 CBRN Contact Hours credits
The content for this activity is based on the satellite symposium, “Current Strategies for the Long-term Assessment, Monitoring, and Management for Cystic Fibrosis Patients Treated with CFTR Modulator Therapy” that was presented at the 39th European Cystic Fibrosis Society Conference on June 10, 2016. The emergence of novel targeted agents, that...
Recent Updates in Novel Therapeutics for the Treatment of Multiple Sclerosis
  • 0.25 AMA PRA Category 1 Credit(s)™ credits
  • 0.25 Non-physician credits
This CME activity will focus on the treatment of multiple sclerosis with recent updates in novel therapeutics. Both new data and long‐term data of available therapies show that patients are able to achieve disease activity free status while receiving these therapies. Expert faculty will discuss the treatment of acute relapses in multiple sclerosis...
AAN 2016: Implementing Disease Modifying Therapies in the Management of...
  • 1.00 AMA PRA Category 1 Credit(s)™ credit
  • 1.00 Non-physician credit
This CME program will focus on information presented at the 68th Annual American Academy of Neurology Meeting held in Vancouver, Canada on April 15-21, 2016. The latest advances in treatment options and methods of slowing disease progression will be discussed by three expert faculty. Recent clinical trial data, including that pertaining to disease...
Shedding Light on Shingles: The Power of Prevention
  • 1.00 AMA PRA Category 1 Credit(s)™ credit
  • 1.00 Non-physician credit
Shingles, or herpes zoster (HZ), is a common secondary infection caused by a reactivated varicella zoster virus (VZV). More than 95% of immunocompetent individuals aged at least 50 years are seropositive for VZV and are therefore at risk for developing HZ. Age-related increased incidence of HZ and its complications are thought to be related to the...
ACC 2016: Recent Advances to Improve Outcomes for Patients with Dyslipidemia
  • 1.00 AMA PRA Category 1 Credit(s)™ credit
  • 1.00 Non-physician credit
This Official Elsevier Medical Meeting Reporter will cover data presented at the American College of Cardiology 65th Annual Scientific Session and Expo held in Chicago, Illinois on April 2-4, 2016. The four expert faculty will communicate imperative information for clinical decision-making, as it relates to the comprehensive healthcare team, in...
Advanced Therapeutics to Address Patient-Specific Disease Activity in Multiple...
  • 1.00 AMA PRA Category 1 Credit(s)™ credit
  • 1.00 Non-physician credit
This CME program will give physicians insight into the ever-growing research in the field of multiple sclerosis. The faculty review MS treatment guidelines and recommendations, including recently updated phenotype descriptions. The experts break down the therapeutic needs in relapsing and progressive MS and analyze novel therapeutics. Emerging...
Strategies to Improve Outcomes in Patients with Asthma
  • 1.00 AMA PRA Category 1 Credit(s)™ credit
  • 1.00 Non-physician credit
This CME Program will provide physicians with imperative information about the rationale of asthma control for each stage of disease. Expert panel will discuss biomarkers of disease activity, new biologics and the asthma and COPD overlap syndrome among other relevant topics. Physicians will also be exposed to different disease monitoring tools as...
New Strategies to Improve Outcomes in Patients with Epilepsy
  • 1.00 AMA PRA Category 1 Credit(s)™ credit
  • 1.00 Non-physician credit
This CME Program will provide clinicians with a comprehensive review and analysis from the American Epilepsy Society (AES) 2015 Annual Meeting held in Philadelphia, Pennsylvania. Expert faculty will communicate important information for clinical decision-making, as it relates to diagnostic classifications of epilepsy. Recent clinical trial data...
An Update on Scientific Advances and Clinical Strategies in Alzheimer’s Disease...
  • 0.50 AMA PRA Category 1 Credit(s)™ credits
  • 0.50 Non-physician credits
The 8th annual meeting of Clinical Trials on Alzheimer’s Disease (CTAD) was held in Barcelona, Spain, November 5-7, 2015. CTAD has become one of the most important scientific meetings in the Alzheimer’s disease (AD) area. It brings together today’s worldwide leaders in AD to discuss new results, candidate therapeutics, and methodological issues...

Pending Activities

Please login or create an account to view your activities.

Transcript

Please login or create an account to view your activities.